Evaluating the Diagnostic Accuracy of Impression Cytology for Conjunctival Lesions: A Comparative Study with Histopathology

Document Type : Original Research

Authors

1 Department of Ophthalmology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

2 Department of Pathology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

3 Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran

Abstract
Background & Objective: Conjunctival lesions have a wide range of histological manifestations that are difficult to distinguish clinically. The gold standard for diagnosis of these lesions is the pathological examination, a costly and invasive procedure that may also adversely affect patients. Therefore, clinical researchers seek less invasive, inexpensive, and easier methods to detect conjunctival lesions. This study aims to compare the accuracy of impression cytology with pathology in patients referred to Farshchian Hospital in Iran.
Methods: In this descriptive/cross-sectional study, 64 patients with conjunctival lesions were selected from patients referred to Farshchian Hospital in Hamedan in 2021. A cytology specimen was obtained from the patients and sent to the laboratory. The diagnostic accuracy of this method was compared with pathological results (gold standard). Data were analyzed by SPSS 16 software.
Results: The mean age of patients was 54.47 ±16.94 years; 70.3% were male, and 29.7% were female. In the cytologic and pathologic examination, 28.1% of the specimens showed dysplasia, and 71.9% were non-dysplastic. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the cytologic impression compared to the pathologic methods were 91.30%, 77.78%, 91.30%, 77.78%, and 87.5%, respectively. A positive and significant correlation was observed between pathological and cytological diagnosis scores (r=0.825, P-value<0.001).
Conclusion: In conjunctival lesions, impression cytology may be  a relatively accurate and sensitive procedure that can distinguish  dysplastic from  non-dysplastic conjunctival lesions.

Highlights

  • Impression cytology is a non- or minimally invasive biopsy technique that can be applied to the conjunctiva, cornea, and limbal area for both diagnosis and follow-up after treatment of tumors.
  • a positive and significant correlation was observed between pathological and cytological diagnosis scores in conjunctival lesions.
  • In conjunctival lesions, impression cytology is a relatively accurate and sensitive procedure that can distinguish between dysplastic and non-dysplastic conjunctival lesions.

Keywords

Subjects


  1. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Indian J Ophthalmol. 2019;67(12):1930-48. [DOI:10.4103/ijo.IJO_2040_19] [PMID] []
  2. Garcia-Onrubia L, Pacheco-Callirgos GE, Garcia-Alvarez C, Munoz-Moreno MF, Garcia-Lagarto E, Almaraz-Gomez A, et al. Clinic-pathological agreement in the diagnosis of conjunctival tumours: Analysis of 195 cases. Arch Soc Esp Oftalmol (Engl Ed). 2023;98(8):440-7. [DOI:10.1016/j.oftale.2023.06.012] [PMID]
  3. Alves LF, Fernandes BF, Burnier JV, Zoroquiain P, Eskenazi DT, Burnier MN, Jr. Incidence of epithelial lesions of the conjunctiva in a review of 12,102 specimens in Canada (Quebec). Arq Bras Oftalmol. 2011;74(1):21-3. [DOI:10.1590/S0004-27492011000100005] [PMID]
  4. Pe'er J. Ocular surface squamous neoplasia: evidence for topical chemotherapy. Int Ophthalmol Clin. 2015;55(1): 9-21. [DOI:10.1097/IIO.0000000000000050] [PMID]
  5. Mittal R, Rath S, Vemuganti GK. Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis. Saudi J Ophthalmol. 2013;27(3):177-86. [DOI:10.1016/j.sjopt.2013.07.002] [PMID]
  6. Radhakrishnan A. Ocular Surface Squamous Neoplasia (OSSN)-A Brief Review. Kerala J Ophthalmol. 2011;23(4):347-51.
  7. Kheir WJ, Tetzlaff MT, Pfeiffer ML, Mulay K, Ozgur O, Morrell G, et al. Epithelial, non-melanocytic and melanocytic proliferations of the ocular surface. Semin Diagn Pathol. 2016;33(3):122-32. [DOI:10.1053/j.semdp.2015.10.006] [PMID]
  8. Alharbi I, Alfawaz AM, Otaif W, Al-Dahmash SA, Alkatan HM. Variable presentations of six conjunctival/limbal ocular surface squamous neoplasia (OSSN) cases: How good is our clinical judgment evidenced by the correlation to the histopathological findings and diagnosis? Int J Surg Case Rep. 2024;116:109359. [DOI:10.1016/j.ijscr.2024.109359] [PMID]
  9. Sjo NC, Heegaard S, Prause JU, von Buchwald C, Lindeberg H. Human papillomavirus in conjunctival papilloma. Br J Ophthalmol. 2001;85(7):785-7. [DOI:10.1136/bjo.85.7.785] [PMID]
  10. Pradhan S, Mohanty SK, Dash S, Bhuyan L, Bhuyan L. Impression cytology's reliability as an effective method for ophthalmic neoplasm detection. J Pharm Bioallied Sci. 2022;14(Suppl 1):S537-S40. [DOI:10.4103/jpbs.jpbs_114_22] [PMID]
  11. Barros Jde N, Almeida SR, Lowen MS, Cunha MC, Gomes JA. Impression cytology in the evaluation of ocular surface tumors: review article. Arq Bras Oftalmol. 2015;78(2):126-32. [DOI:10.5935/0004-2749.20150033] [PMID]
  12. Rudkin AK, Dodd T, Muecke JS. The differential diagnosis of localised amelanotic limbal lesions: a review of 162 consecutive excisions. Br J Ophthalmol. 2011;95(3):350-4. [DOI:10.1136/bjo.2009.172189] [PMID]
  13. Rezaei Kanavi M, Hosseini B, Javadi F, Rakhshani N, Javadi MA. Impression cytology in eyes with clinical and confocal scan features of acanthamoeba keratitis. J Ophthalmic Vis Res. 2013;8(3):207-12.
  14. Tole DM, McKelvie PA, Daniell M. Reliability of impression cytology for the diagnosis of ocular surface squamous neoplasia employing the Biopore membrane. Br J Ophthalmol. 2001;85(2):154-8. [DOI:10.1136/bjo.85.2.154] [PMID]
  15. Puangsricharern V, Tseng SC. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995;102(10):1476-85. [DOI:10.1016/S0161-6420(95)30842-1] [PMID]
  16. Piccione J, Vallone LV, editors. Cytology of the Eyes and Associated Structures2021. [DOI:10.1002/9781119500186.ch13]
  17. Hagan S. Biomarkers of ocular surface disease using impression cytology. Biomark Med. 2017;11(12):1135-47. [DOI:10.2217/bmm-2017-0124] [PMID]
  18. Moshtaghion SM, Abolhosseini M, Rezaei Kanavi M, Hosseini SB, Rezaei Kanavi M. Impression cytology for detection of clinically suspected ocular surface disorders: A cross-sectional study. Eur J Ophthalmol. 2021;31(3):943-50. [DOI:10.1177/1120672120932093] [PMID]
  19. Kanavi MR, Hosseini SB, Aliakbar-Navahi R, Aghaei H. Impression Cytology in a Series of Clinically Diagnosed Ocular Surface Melanocytic Lesions. J Ophthalmic Vis Res. 2017;12(1):17-22. [DOI:10.4103/jovr.jovr_72_16] [PMID]
  20. Barros JN, Lowen MS, Ballalai PL, Mascaro VL, Gomes JA, Martins MC. Predictive index to differentiate invasive squamous cell carcinoma from preinvasive ocular surface lesions by impression cytology. Br J Ophthalmol. 2009;93(2):209-14. [DOI:10.1136/bjo.2008.147710] [PMID]
  21. Laver NMV. Ocular cytology: Diagnostic features and ongoing practices. Cancer Cytopathol. 2021;129(6): 419-31. [DOI:10.1002/cncy.22384] [PMID]
  22. Nanji AA, Mercado C, Galor A, Dubovy S, Karp CL. Updates in Ocular Surface Tumor Diagnostics. Int Ophthalmol Clin. 2017;57(3):47-62. [DOI:10.1097/IIO.0000000000000174] [PMID]
  23. Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985;92(6): 728-33. [DOI:10.1016/S0161-6420(85)33967-2] [PMID]
  24. Basti S, Macsai MS. Ocular surface squamous neoplasia: a review. Cornea. 2003;22(7):687-704. [DOI:10.1097/00003226-200310000-00015] [PMID]
  25. Gichuhi S, Macharia E, Kabiru J, Zindamoyen AM, Rono H, Ollando E, et al. Risk factors for ocular surface squamous neoplasia in Kenya: a case-control study. Trop Med Int Health. 2016;21(12):1522-30. [DOI:10.1111/tmi.12792] [PMID]
  26. Hӧllhumer R, Michelow P, Williams S. Demographics, clinical presentation and risk factors of ocular surface squamous neoplasia at a tertiary hospital, South Africa. Eye (Lond). 2023;37(17):3602-8. [DOI:10.1038/s41433-023-02565-1] [PMID]
  27. Singh A, Sharma A, Srivastava S, Jaiswal A, Mere K, Dixit H, et al. Cytomorphological Spectrum of Ocular Surface Squamous Neoplasia in Elderly Age Group and Its Clinicopathological Correlation. J Pharm Bioallied Sci. 2024;16(Suppl 3):S2624-S7. [DOI:10.4103/jpbs.jpbs_410_24] [PMID]
  28. Fatima M, Kumar P, Dubey S, Choudhury M. Correlation of Imprint Cytology and Histopathology of Tumours in a Tertiary Care Hospital. Int J Contemp Pathol. 2019;5(2). [DOI:10.5958/2395-1184.2019.00026.3]
  29. Barros JD, Lowen MS, Moraes-Filho MN, Martins MC. Use of impression cytology for the detection of unsuspected ocular surface squamous neoplasia cells in pterygia. Arq Bras Oftalmol. 2014;77(5):305-9. [DOI:10.5935/0004-2749.20140077] [PMID]
  30. Pradhan S, Mohanty SK, Dash S, Bhuyan L, Bhuyan L. Impression Cytology's Reliability as an Effective Method for Ophthalmic Neoplasm Detection. J Pharm Bioallied Sci. 2022;14(Suppl 1):S537-s40. [DOI:10.4103/jpbs.jpbs_114_22] [PMID]
  31. Tananuvat N, Lertprasertsuk N, Mahanupap P, Noppanakeepong P. Role of impression cytology in diagnosis of ocular surface neoplasia. Cornea. 2008;27(3):269-74. [DOI:10.1097/ICO.0b013e31815b9402] [PMID]
  32. A S, M D. - Student evaluation of the academic advising process in an Iranian medical school. Int J Med Educ. 2012;3:17-20. [DOI:10.5116/ijme.4f29.a809]
  33. Thakre A, Maheshgauri R, Aggarwal M, Mantri P, Naik A. Role of impression cytology in ocular surface disorders. IP Int J Ocul Oncol Oculoplasty. 2020;6(1):42-7. [DOI:10.18231/j.ijooo.2020.008]
  34. Elwan A, Aly M, Hegazy H, Abosaif AI. Conjunctival Impression Cytology in Patients with Thyroid Disorders. Int J Med Arts. 2022. [DOI:10.21608/ijma.2022.106467.1394]
  35. Sinha S, Ramesh PV, Nishant P, Morya AK, Prasad R. Novel automated non-invasive detection of ocular surface squamous neoplasia using artificial intelligence. World J Methodol. 2024;14(2):92267.    [DOI:10.5662/wjm.v14.i2.92267] [PMID]
Volume 20, Issue 1
Winter 2025
Pages 49-57

  • Receive Date 10 April 2024
  • Revise Date 09 August 2024
  • Accept Date 03 September 2024